NV-07a: NVGN began a Phase I of NV-07a in 15 nickel sensitive patients and 15 mantoux positive patients.

Novogen Ltd. (NVGN; ASX:NRT), Sydney,

Read the full 56 word article

How to gain access

Continue reading with a
two-week free trial.